These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20210561)

  • 1. A novel polymethylmethacrylate hydrophilic adhesive matrix intended for transdermal patch formulations.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Montanari L
    Drug Deliv; 2010 Apr; 17(3):171-7. PubMed ID: 20210561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a new water-soluble pressure-sensitive adhesive for patch preparation.
    Minghetti Y; Cilurzo F; Tosi L; Casiraghi A; Montanari L
    AAPS PharmSciTech; 2003; 4(1):E8. PubMed ID: 12916917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
    Lee PJ; Langer R; Shastri VP
    J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of ubidecarenone transdermal delivery systems.
    Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-layer transdermal film containing lidocaine: modulation of drug release.
    Padula C; Nicoli S; Colombo P; Santi P
    Eur J Pharm Biopharm; 2007 Jun; 66(3):422-8. PubMed ID: 17196804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK; Ryoo JP; Moon C; Choi HK
    Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel controlled porosity osmotic pump system for sodium ferulate.
    He L; Gong T; Zhao D; Zhang ZR; Li L
    Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended release of lidocaine from linker-based lecithin microemulsions.
    Yuan JS; Acosta EJ
    Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of the Sinomenine transdermal patch.
    Wang J; Ruan J; Zhang C; Ye Y; Cai Y; Wu Y
    Pak J Pharm Sci; 2008 Oct; 21(4):407-10. PubMed ID: 18930863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of transdermal permeation in vitro of lidocaine tincture and microemulsion].
    Huang L; Chen ZL; Li GF; Zhu XL; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):541-2. PubMed ID: 17545055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-sensitive adhesive properties of poly(N-vinyl pyrrolidone)/D,L-lactic acid oligomer/glycerol/water blends for TDDS.
    Zhang J; Deng L; Zhao H; Liu M; Jin H; Li J; Dong A
    J Biomater Sci Polym Ed; 2010; 21(1):1-15. PubMed ID: 20040150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug transformation: Advances in drug delivery systems.
    Hung O
    Can J Anaesth; 2006 Nov; 53(11):1074-7. PubMed ID: 17079632
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI; Boix A; Lauroba J; Colom H; Domenech J
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.